Drug Type Small molecule drug |
Synonyms DAT-1000, DAT-1604 |
Target |
Action inhibitors |
Mechanism POLQ inhibitors(DNA polymerase theta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Phase 1 | China | 19 Aug 2025 | |
| Castration-Resistant Prostatic Cancer | Phase 1 | China | 19 Aug 2025 | |
| Ovarian Cancer | Phase 1 | China | 19 Aug 2025 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 31 Jul 2025 | |
| Locally Advanced Malignant Solid Neoplasm | IND Approval | China | 18 Jun 2025 | |
| Metastatic Solid Tumor | IND Approval | China | 18 Jun 2025 |





